Lisy Wang

2.6k citations
40 papers · 2.0k · 2 hit papers · h-index 17

Impact in

  • Rheumatology top 0.5%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Hematology top 1%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Rheumatoid Arthritis Research and Therapies 31
    • Spondyloarthritis Studies and Treatments 6
    • Systemic Lupus Erythematosus Research 5
    • Autoimmune and Inflammatory Disorders Research 19

Lisy Wang

39 papers receiving 1.9k citations

Hit Papers

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study 2021 · 159 citations
1590+3+6Years since publication100200300

Peers

Lisy Wang
Comparison fields: 5 of 82
  • Rheumatology 1.3k
  • Hematology 676
  • Genetics 332
  • Immunology 459
  • Dermatology 170
Replace Koshika Soma with:
Koshika Soma United States
Birgitta Benda Sweden
Pille Harrison United Kingdom
S. Kary Germany
Serena Bugatti Italy
Marie‐Christine Jacob France
Bernard Lauwerys Belgium
Mark C. Totoritis United States
Michihide Tokuhira Japan
Michel Tulliez France
Lisy Wang relative to Koshika Soma United States Koshika Soma's profile →
Citations per field
00.5×1.5×
Koshika Soma · 1×
Citations per year

Countries citing papers authored by Lisy Wang

Since Specialization
Citations

This map shows the geographic impact of Lisy Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisy Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisy Wang more than expected).

Fields of papers citing papers by Lisy Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisy Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisy Wang. The network helps show where Lisy Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lisy Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lisy Wang Line = papers co-authored together Lisy Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Hit paper breakdown →
2017302
2 2014253
3 2019238
4 2017182
5
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
Hit paper breakdown →
2021159
6 2020135
7 2015125
8 2014117
9 201669
10 199845
11 201838
12 201733
13 202132
14 201827
15 202227
16 202119
17 201918
18 201615
19 202215
20 201814

About Lisy Wang

Lisy Wang is a scholar working on Rheumatology, Hematology, Genetics, Pharmacology and Pathology and Forensic Medicine, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (31 papers), Autoimmune and Inflammatory Disorders Research (19 papers), Chronic Lymphocytic Leukemia Research (11 papers), Spondyloarthritis Studies and Treatments (6 papers), Biosimilars and Bioanalytical Methods (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). The work is most often cited by research in Rheumatology (1.3k citations), Hematology (676 citations), Genetics (332 citations), Immunology (459 citations) and Dermatology (170 citations). Lisy Wang has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Jeffrey R. Curtis, J. Wollenhaupt, Kenneth Kwok, Eun Bong Lee, Richard J. Riese, Koshika Soma, Stanley Cohen, Ryan DeMasi, Yoshiya Tanaka and Kevin Winthrop. Their work appears in journals such as Annals of the Rheumatic Diseases, Rheumatology and Therapy, RMD Open, Arthritis & Rheumatology and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact